Innovative Journal Advanced Research Journal of Medical and Clinical Sciences 2455-3549 07 03 2021 3 30 MOLECULAR DIAGNOSIS: A BOON FOR LEUKAEMIA 1 1.Trishna Priyadarshini Research Trainee, Regional Institute of Biotechnology, Bhubaneswar, Odisha, India 2.Sanjeet Manna Research Coordinator, Regional Institute of Biotechnology, Bhubaneswar, Odisha, India Journal Article https://doi.org/10.15520/arjmcs.v7i03.267 Abstract In hematologic malignancies, leukaemia is categorized as the unusual proliferation of the hematopoietic cells. The confirmatory diagnosis is usually made on the aspirate of the bone marrow with or without trephine biopsy by visualizing the cell morphology and the architecture of the bone marrow. Furthermore, there are additional methods that are used to further categorize the variant of leukaemia that includes flow cytometry immune phenotyping, and genetic analysis. In India also use of molecular diagnosis is increasing rapidly for the detection of leukaemia. Techniques such as FISH and PCR are very sensitive and with accurate results have gained importance for cancer diagnosis. Further with the development of next-generation sequencing, it is likely to become an even more prominent practice in cancer diagnosis. This article focuses and elaborated on the molecular diagnosis of leukaemia Leukaemia, - Uk, Incidence, 2021, http://info.cancerresearchuk.org/cancerstats/types/leukaemia/incidence(Lastaccessedon27th , WHO report on cancer: setting priorities, investing wisely and providing care for all. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. Swerdlow, S H, Campo, E, Harris, N L, World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon, France, 2008 Craig, Fiona E., Foon, Kenneth A., Flow cytometric immunophenotyping for hematologic neoplasms, Blood, 2008, 111, 8, 3941, 3967, 0006-4971, 1528-0020, 10.1182/blood-2007-11-120535, American Society of Hematology, https://dx.doi.org/10.1182/blood-2007-11-120535 Mason, Joanne, Griffiths, Michael, Molecular diagnosis of leukemia, Expert Review of Molecular Diagnostics, 2012, 12, 5, 511, 526, 1473-7159, 1744-8352, 10.1586/erm.12.44, Informa UK Limited, https://dx.doi.org/10.1586/erm.12.44 Maciejewski, Jaroslaw P., Tiu, Ramon V., O’Keefe, Christine, Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies, British Journal of Haematology, 2009, 146, 5, 479, 488, 0007-1048, 1365-2141, 10.1111/j.1365-2141.2009.07757.x, Wiley, https://dx.doi.org/10.1111/j.1365-2141.2009.07757.x Betz, Bryan L., Hess, Jay L., Acute Myeloid Leukemia Diagnosis in the 21st Century, Archives of Pathology & Laboratory Medicine, 2010, 134, 10, 1427, 1433, 0003-9985, 1543-2165, 10.5858/2010-0245-ra.1, Archives of Pathology and Laboratory Medicine, https://dx.doi.org/10.5858/2010-0245-ra.1 Grimwade, D, , Acute Myelogenous Leukemia. Karp JE, Impact of cytogenetics on clinical outcome in AML, Humana Press, NY, USA, 2007, 177, 192 Fabarius, A, Leitner, A, Hochhaus, A, Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML study group. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML study IV, Blood, 2011, 118, 26, 6760, 6768 Harrison, Christine J., Haas, Oskar, Harbott, Jochen, Biondi, Andrea, Stanulla, Martin, Trka, Jan, Izraeli, Shai, Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfürt-Münster study group, British Journal of Haematology, 2010, 151, 2, 132, 142, 0007-1048, 10.1111/j.1365-2141.2010.08314.x, Wiley, https://dx.doi.org/10.1111/j.1365-2141.2010.08314.x Döhner, Hartmut, Stilgenbauer, Stephan, Benner, Axel, Leupolt, Elke, Kröber, Alexander, Bullinger, Lars, Döhner, Konstanze, Bentz, Martin, Lichter, Peter, Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia, New England Journal of Medicine, 2000, 343, 26, 1910, 1916, 0028-4793, 1533-4406, 10.1056/nejm200012283432602, Massachusetts Medical Society, https://dx.doi.org/10.1056/nejm200012283432602 Maciejewski, Jaroslaw P., Mufti, Ghulam J., Whole genome scanning as a cytogenetic tool in hematologic malignancies, Blood, 2008, 112, 4, 965, 974, 0006-4971, 1528-0020, 10.1182/blood-2008-02-130435, American Society of Hematology, https://dx.doi.org/10.1182/blood-2008-02-130435 Tyybäkinoja, A., Vilpo, J., Knuutila, S., High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia, Cytogenetic and Genome Research, 2007, 118, 1, 8, 12, 1424-8581, 1424-859X, 10.1159/000106435, S. Karger AG, https://dx.doi.org/10.1159/000106435 Engle, L J, Simpson, C L, Landers, J E, Using high-throughput SNP technologies to study cancer, Oncogene, 2006, 25, 11, 1594, 1601, 0950-9232, 1476-5594, 10.1038/sj.onc.1209368, Springer Science and Business Media LLC, https://dx.doi.org/10.1038/sj.onc.1209368 Gunnarsson, R., Mansouri, L., Isaksson, A., Goransson, H., Cahill, N., Jansson, M., Rasmussen, M., Lundin, J., Norin, S., Buhl, A. M., Smedby, K. E., Hjalgrim, H., Karlsson, K., Jurlander, J., Geisler, C., Juliusson, G., Rosenquist, R., Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia, Haematologica, 2011, 96, 8, 1161, 1169, 0390-6078, 1592-8721, 10.3324/haematol.2010.039768, Ferrata Storti Foundation (Haematologica), https://dx.doi.org/10.3324/haematol.2010.039768 Li, Xiaohong, Self, Steven G, Galipeau, Patricia C, Paulson, Thomas G, Reid, Brian J, Direct Inference of SNP Heterozygosity Rates and Resolution of LOH Detection, PLoS Computational Biology, 2007, 3, 11, e244, e244, 1553-7358, 10.1371/journal.pcbi.0030244, Public Library of Science (PLoS), https://dx.doi.org/10.1371/journal.pcbi.0030244 Mason, Joanne, Akiki, Susanna, Griffiths, Mike J, Pitfalls in molecular diagnosis in haemato-oncology, Journal of Clinical Pathology, 2011, 64, 4, 275, 278, 0021-9746, 1472-4146, 10.1136/jcp.2010.081349, BMJ, https://dx.doi.org/10.1136/jcp.2010.081349 Cazzaniga, Giovanni, Valsecchi, Maria Grazia, Gaipa, Giuseppe, Conter, Valentino, Biondi, Andrea, Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia, British Journal of Haematology, 2011, 155, 1, 45, 52, 0007-1048, 10.1111/j.1365-2141.2011.08795.x, Wiley, https://dx.doi.org/10.1111/j.1365-2141.2011.08795.x Dworzak, Michael N., Fröschl, Gertraud, Printz, Dieter, Mann, Georg, Pötschger, Ulrike, Mühlegger, Nora, Fritsch, Gerhard, Gadner, Helmut, Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia, Blood, 2002, 99, 6, 1952, 1958, 0006-4971, 1528-0020, 10.1182/blood.v99.6.1952, American Society of Hematology, https://dx.doi.org/10.1182/blood.v99.6.1952 Schouten, J. P., Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Research, 2002, 30, 12, 57e, 57, 1362-4962, 10.1093/nar/gnf056, Oxford University Press (OUP), https://dx.doi.org/10.1093/nar/gnf056 Preuner, S, Denk, D, Frommlet, F, Nesslboeck, M, Lion, T, Quantitative monitoring of cell clones carrying point mutations in the BCR–ABL tyrosine kinase domain by ligation-dependent polymerase chain reaction (LD–PCR), Leukemia, 2008, 22, 10, 1956, 1961, 0887-6924, 1476-5551, 10.1038/leu.2008.97, Springer Science and Business Media LLC, https://dx.doi.org/10.1038/leu.2008.97 Neumann, Frank, Herold, Caroline, Hildebrandt, Barbara, Kobbe, Guido, Aivado, Manuel, Rong, Astrid, Free, Maren, Rössig, Renate, Fenk, Roland, Schneider, Peter, Gattermann, Norbert, Royer-Pokora, Brigitte, Haas, Rainer, Kronenwett, Ralf, Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation, European Journal of Haematology, 2003, 70, 1, 1, 10, 0902-4441, 10.1034/j.1600-0609.2003.02811.x, Wiley, https://dx.doi.org/10.1034/j.1600-0609.2003.02811.x Vogelstein, B., Kinzler, K. W., Digital PCR, Proceedings of the National Academy of Sciences, 1999, 96, 16, 9236, 9241, 0027-8424, 1091-6490, 10.1073/pnas.96.16.9236, Proceedings of the National Academy of Sciences, https://dx.doi.org/10.1073/pnas.96.16.9236 Goh, H G, Lin, M, Fukushima, T, Sensitive quantitation of minimal residual disease in chronic myeloid leukaemia using nanofluidic digital polymerase chain reaction assay, Leuk. Lymphoma, 2011, 52, 5, 896, 904 Corless, Christopher L., Harrell, Patina, Lacouture, Mario, Bainbridge, Troy, Le, Claudia, Gatter, Ken, White, Clifton, Granter, Scott, Heinrich, Michael C., Allele-Specific Polymerase Chain Reaction for the Imatinib-Resistant KIT D816V and D816F Mutations in Mastocytosis and Acute Myelogenous Leukemia, The Journal of Molecular Diagnostics, 2006, 8, 5, 604, 612, 1525-1578, 10.2353/jmoldx.2006.060089, Elsevier BV, https://dx.doi.org/10.2353/jmoldx.2006.060089 Kristensen, Thomas, Vestergaard, Hanne, Møller, Michael Boe, Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay, The Journal of Molecular Diagnostics, 2011, 13, 2, 180, 188, 1525-1578, 10.1016/j.jmoldx.2010.10.004, Elsevier BV, https://dx.doi.org/10.1016/j.jmoldx.2010.10.004 Banjar, Haneen, Adelson, David, Brown, Fred, Chaudhri, Naeem, Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System, BioMed Research International, 2017, 2017, 1, 21, 2314-6133, 2314-6141, 10.1155/2017/3587309, Hindawi Limited, https://dx.doi.org/10.1155/2017/3587309